Life Sciences Tools and Services
Company Overview of mBio Diagnostics, Inc.
mBio Diagnostics, Inc. develops clinical diagnostics and sample testing products that deliver on-the-spot results. It offers MBio multiplex analyzers and disposable cartridges that are used for clinical and analytical testing applications in medical, veterinary, environmental, food, agricultural, and military markets. It also provides MBio array systems, which are multiplexed fluorescence immunoassay systems that provide the simultaneous measurement of multiple analytes from a single sample; and LightDeck devices, which are fluorescence assay illumination systems. The company was founded in 2009 and is based in Boulder, Colorado.
5603 Arapahoe Avenueo
Boulder, CO 80301
Founded in 2009
Key Executives for mBio Diagnostics, Inc.
Founder, Chief Executive Officer and Director
Director of Finance & Administration
Chief Technology Officer and Executive Vice President
Compensation as of Fiscal Year 2014.
mBio Diagnostics, Inc. Key Developments
MBio Diagnostics, Inc. Wins Contract for Diagnostic Development With the U.S. Army
Nov 4 14
MBio Diagnostics, Inc. announced it was awarded a three-year development contract with the U.S. Army's Walter Reed Army Institute of Research (WRAIR) for the Development of a Ruggedized Portable Cartridge Reader for Malaria Diagnosis.Under this contract, MBio Diagnostics will develop a low cost, multi-analyte point-of-care (POC) diagnostic device for malaria with enhanced sensitivity, quantitation capabilities, and automated data capture and transmission, using the company's planar waveguide LightDeck(R) technology. The work will be carried out collaboratively with Dr. John Waitumbi of the United States Army Medical Research Unit-Kenya (USAMRU-K), which is a Special Foreign Activity of the WRAIR headquartered in Nairobi, Kenya. The USAMRU-K unit develops and tests improved means for predicting, detecting, preventing, and treating infectious disease threats important to the U.S. Military as well as conducts surveillance, training, research and response activities related to emerging infectious diseases threats.
MBio Diagnostics, Inc. Announces Creation of Scientific Advisory Board
Oct 29 13
MBio Diagnostics, Inc. announced the formation of a Scientific Advisory Board (SAB) composed of medical professionals with deep expertise in global health issues. The SAB will help advance MBio Diagnostics' mission to increase access to quality healthcare by delivering innovative and low cost point-of-care (POC) diagnostics. Board members will assist the management team with assessing technology options, developing new POC diagnostics in limited-resource settings, and will provide expertise on future clinical diagnostics trends. Robert Schooley, M.D. is the Division Head and Professor of Medicine in the Department of Medicine, Division of Infectious Disease, at the University of California, San Diego (UCSD). Dr. Benson, M.D. is a Professor of Medicine, Senior Attending Physician, and the Infectious Disease Fellowship Training Program Director in the Department of Medicine/Division of Infectious Disease at the University of California, San Diego School of Medicine. She is the principal investigator and Chair of the Executive Committee and Vice Chair of the Scientific Steering Committee of the NIH/NIAID AIDS Clinical Trials Group (ACTG), and is a past chair of the NIH Office of AIDS Research Advisory Council. Bruce Walker, M.D. is the Director of the Ragon Institute of MGH, MIT, and Harvard, a Professor of Medicine at Harvard Medical School, and a Howard Hughes Medical Institute Investigator.
MBio Diagnostics, Inc. Appoints Robert J. Silverman as Board of Directors
Aug 22 13
MBio Diagnostics, Inc. announced that it has appointed Robert J. Silverman to the company board of directors. Mr. Silverman served as the CEO of mtm Laboratories AG. He was instrumental in raising capital and building mtm into a global, fully integrated commercial business.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 7, 2015